Great Valley Advisor Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $346K | Buy |
4,949
+957
| +24% | +$66.8K | 0.01% | 708 |
|
|
2025
Q1 | $293K | Sell |
3,992
-81
| -2% | -$5.95K | 0.01% | 732 |
|
|
2024
Q4 | $267K | Sell |
4,073
-54
| -1% | -$3.54K | 0.01% | 724 |
|
|
2024
Q3 | $321K | Sell |
4,127
-171
| -4% | -$13.3K | 0.01% | 673 |
|
|
2024
Q2 | $335K | Sell |
4,298
-288
| -6% | -$22.4K | 0.01% | 618 |
|
|
2024
Q1 | $310K | Buy |
4,586
+749
| +20% | +$50.7K | 0.01% | 601 |
|
|
2023
Q4 | $259K | Sell |
3,837
-474
| -11% | -$32K | 0.01% | 615 |
|
|
2023
Q3 | $292K | Buy |
4,311
+835
| +24% | +$56.5K | 0.01% | 553 |
|
|
2023
Q2 | $249K | Buy |
3,476
+74
| +2% | +$5.3K | 0.01% | 612 |
|
|
2023
Q1 | $236K | Sell |
3,402
-515
| -13% | -$35.7K | 0.01% | 609 |
|
|
2022
Q4 | $265K | Buy |
+3,917
| New | +$265K | 0.01% | 576 |
|
|
2022
Q3 | – | Sell |
-3,247
| Closed | -$215K | – | 677 |
|
|
2022
Q2 | $215K | Buy |
+3,247
| New | +$215K | 0.01% | 619 |
|
|
2021
Q4 | – | Sell |
-4,268
| Closed | -$256K | – | 596 |
|
|
2021
Q3 | $256K | Sell |
4,268
-1,679
| -28% | -$101K | 0.02% | 503 |
|
|
2021
Q2 | $339K | Buy |
5,947
+45
| +0.8% | +$2.57K | 0.03% | 427 |
|
|
2021
Q1 | $293K | Sell |
5,902
-23,361
| -80% | -$1.16M | 0.03% | 410 |
|
|
2020
Q4 | $1.46M | Buy |
29,263
+997
| +4% | +$49.8K | 0.15% | 151 |
|
|
2020
Q3 | $1.55M | Buy |
+28,266
| New | +$1.55M | 0.19% | 115 |
|